MDCX
Medicus Pharma Ltd. Common Stock NASDAQ Listed Nov 15, 2024$0.26
-3.77%
vs $0.27
Mkt Cap $5.7M
52w Low $0.24
0.5% of range
52w High $3.05
50d MA $0.35
200d MA $0.84
P/E (TTM)
—
EV/EBITDA
—
P/B
117.1x
Debt/Equity
-59.1x
ROE
69990.7%
P/FCF
-0.2x
RSI (14)
34.40
ATR (14)
$0.03
Beta
-0.04
50d MA
$0.35
200d MA
$0.84
Avg Volume
1.6M
Medicus Pharma Ltd. is a biotech/life sciences company focused on accelerating the clinical development programs of novel and disruptive therapeutic assets, with an emphasis on non-invasive treatments for skin cancer.
300 Conshohocken State Rd. Suite 200 · W. Conshohocken, PA 19428 · CA
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 14, 2026 | AMC | -0.18 | -0.31 | -72.2% | 0.34 | -6.5% | -10.7% | -3.3% | -4.5% | +4.3% | -1.4% | — |
| Mar 25, 2026 | AMC | -0.32 | -0.82 | -156.2% | 0.49 | +1.2% | -5.7% | -3.4% | -9.6% | +12.9% | -8.5% | — |
| Nov 14, 2025 | AMC | -0.38 | -0.65 | -71.1% | 2.20 | +4.5% | +4.5% | -7.0% | +4.7% | -8.9% | +4.4% | — |
| Aug 11, 2025 | AMC | -0.39 | -0.43 | -10.3% | 1.97 | -0.5% | +13.7% | -6.2% | -5.7% | -1.0% | +2.0% | — |
| May 12, 2025 | AMC | -0.23 | -0.42 | -82.6% | 4.86 | +8.6% | +13.2% | +14.9% | -5.9% | +13.1% | +15.6% | — |
| Mar 28, 2025 | AMC | -0.32 | -0.18 | +43.8% | 3.13 | +3.5% | +18.8% | +6.5% | -14.1% | +10.3% | -3.5% | — |
| Nov 22, 2024 | AMC | -0.22 | -0.31 | -40.6% | 1.92 | +9.4% | +7.8% | +1.4% | +21.0% | +6.3% | -8.9% | — |
| Aug 22, 2024 | AMC | -0.15 | -0.34 | -126.7% | — | — | — | — | — | — | — | — |
| May 30, 2024 | AMC | -0.18 | -0.15 | +16.7% | — | — | — | — | — | — | — | — |
| Dec 31, 2023 | AMC | -0.30 | -0.31 | -2.0% | — | — | — | — | — | — | — | — |
| Sep 30, 2023 | AMC | — | -1.47 | — | — | — | — | — | — | — | — | — |
| Jun 30, 2023 | AMC | — | -0.06 | — | — | — | — | — | — | — | — | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 20 | D. Boral Capital | Maintains | Buy → Buy | — | $0.35 | $0.34 | -3.3% | -2.1% | -4.7% | +3.4% | -2.0% | -5.2% |
| Mar 19 | D. Boral Capital | Maintains | Buy → Buy | — | $0.50 | $0.49 | -2.2% | +0.0% | +1.8% | -1.8% | -2.2% | +1.0% |
| Mar 9 | D. Boral Capital | Maintains | Buy → Buy | — | $0.39 | $0.40 | +3.3% | +34.3% | -3.1% | -3.7% | +3.1% | +9.1% |
| Dec 15 | D. Boral Capital | Maintains | Buy → Buy | — | $1.89 | $1.98 | +4.8% | -3.2% | -1.6% | -6.1% | -1.8% | +1.8% |
| Nov 17 | D. Boral Capital | Maintains | Buy → Buy | — | $2.20 | $2.30 | +4.5% | +4.5% | -7.0% | +4.7% | -8.9% | +4.4% |
| Nov 13 | D. Boral Capital | Maintains | Buy → Buy | — | $2.39 | $2.39 | +0.0% | -5.4% | -2.7% | +4.5% | -7.0% | +4.7% |
| Oct 29 | D. Boral Capital | Maintains | Buy → Buy | — | $2.41 | $2.37 | -1.7% | -4.6% | +7.4% | -1.2% | -4.1% | -6.0% |
| Oct 22 | D. Boral Capital | Maintains | Buy → Buy | — | $2.38 | $2.44 | +2.5% | +0.0% | +2.1% | +11.1% | -11.5% | +0.8% |
| Oct 14 | D. Boral Capital | Maintains | Buy → Buy | — | $2.32 | $2.35 | +1.3% | +2.6% | -3.8% | +5.2% | -2.1% | +5.5% |
| Sep 29 | D. Boral Capital | Maintains | Buy → Buy | — | $2.63 | $2.59 | -1.5% | -4.6% | -7.6% | -3.4% | +12.1% | +1.2% |
| Sep 2 | D. Boral Capital | Maintains | Buy → Buy | — | $1.94 | $1.95 | +0.5% | +7.2% | -4.3% | -8.0% | +2.7% | +11.2% |
| Aug 22 | D. Boral Capital | Maintains | Buy → Buy | — | $2.45 | $2.22 | -9.4% | -9.4% | -2.3% | -6.0% | -0.5% | -1.5% |
| Aug 13 | D. Boral Capital | Maintains | Buy → Buy | — | $2.24 | $2.24 | +0.0% | -6.2% | -5.7% | -1.0% | +2.0% | -2.0% |
| Jul 9 | D. Boral Capital | Maintains | Buy → Buy | — | $2.99 | $3.34 | +11.7% | +10.7% | -0.3% | -8.2% | +3.3% | -5.1% |
| Jul 1 | D. Boral Capital | Maintains | Buy → Buy | — | $2.99 | $3.00 | +0.3% | -1.3% | +9.2% | +5.0% | +0.6% | -12.1% |
| Jun 23 | D. Boral Capital | Maintains | Buy → Buy | — | $2.49 | $2.51 | +0.8% | -6.0% | +4.7% | +11.4% | +13.6% | -6.5% |
| Jun 9 | D. Boral Capital | Maintains | Buy → Buy | — | $2.76 | $2.79 | +1.1% | +4.3% | +2.4% | -9.5% | +4.5% | -6.8% |
| May 29 | D. Boral Capital | Maintains | Buy → Buy | — | $4.12 | $4.61 | +11.9% | -11.7% | -29.9% | +3.1% | -3.8% | +8.7% |
| May 22 | D. Boral Capital | Maintains | Buy → Buy | — | $7.71 | $8.20 | +6.4% | -8.2% | +3.0% | -15.5% | -33.1% | -11.7% |
| May 12 | D. Boral Capital | Maintains | Buy → Buy | — | $4.59 | $5.00 | +8.9% | +5.9% | +13.2% | +14.9% | -5.9% | +13.1% |
| May 8 | Maxim Group | Maintains | Buy → Buy | — | $4.27 | $4.37 | +2.3% | -2.1% | +9.8% | +5.9% | +13.2% | +14.9% |
| Apr 28 | D. Boral Capital | Maintains | Buy → Buy | — | $3.95 | $4.24 | +7.3% | +3.5% | -2.0% | +4.7% | +2.9% | +2.1% |
| Apr 21 | D. Boral Capital | Maintains | Buy → Buy | — | $4.00 | $4.33 | +8.2% | +1.5% | -6.7% | +3.4% | +1.0% | -0.3% |
No insider trades available.
8-K · 1.01
! Medium
Medicus Pharma Ltd. -- 8-K 1.01: Financing / Debt Agreement
May 27
8-K · 1.01
!! High
Medicus Pharma Ltd. -- 8-K 1.01: Material Agreement
Medicus Pharma secured an $11.5 million equity distribution agreement with Maxim Group LLC, enabling the company to raise capital through controlled stock offerings to fund operations and growth initiatives.
Apr 24
8-K
Medicus Pharma Ltd. -- 8-K Filing
Medicus Pharma raised capital by selling common shares to Yorkville Advisors in a private placement exempt from SEC registration requirements.
Mar 6
Valuation
Market Cap
$5.7M
Enterprise Value
-$4.2M
P/E (TTM)
—
Forward P/E
—
PEG Ratio
-0.01x
P/B
117.14x
P/S
—
P/FCF
-0.20x
EV/EBITDA
—
Shares Out
17.3M
Financials (TTM)
Revenue
$0
Net Income
-$36.9M
EBITDA
-$37.1M
Free Cash Flow
-$22.8M
Op Cash Flow
-$22.8M
EPS Basic
$-1.96
EPS Diluted
$-2.20
EPS Forward
$-0.58
Gross Margin
—
Op Margin
—
Net Margin
—
Balance Sheet
Total Assets
$10.1M
Total Liab.
$10.0M
Total Equity
$37K
Cash
$8.7M
LT Debt
$19K
Book Value/Sh
$0.00
Debt/Equity
-59.15x
Current Ratio
1.00
Quick Ratio
1.00
Returns & Growth
ROE
69990.7%
ROA
-469.9%
ROIC
-452.4%
Rev Growth YoY
+0.0%
EPS Growth YoY
-78.2%
Price Returns
2W
-8.0%
1M
-4.6%
3M
-32.0%
6M
-83.2%
12M
-86.7%
Technicals
52W High
$3.05
52W Low
$0.24
50d MA
$0.35
200d MA
$0.84
RSI (14)
34.40
ATR (14)
$0.03
Beta
-0.04
Avg Volume
1.6M
Dividends
Div Rate
$0.00
Div Yield
—
Frequency
—
Ex-Div Date
—
Analyst Price Targets
Consensus
—
High
—
Low
—
Median
—
Data updated apr 26, 2026 11:39am
· Source: financialmodelingprep.com